10 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 14 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 14 | Completed 10, Terminated 2, Active not recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Completed 2 |
Follow Borrelia Infections: new trials by email Literature Review of Borrelia Infections trials Research Report on Borrelia Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine VLA15, Placebo - Lyme Disease | Phase 3 | Recruiting | Pfizer | 1712 | 2026-04-08 | 2026-05-06 |
| A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults VLA15, Placebo - Lyme Borreliosis | Phase 3 | Active not recruiting | Pfizer | 207 | 2025-11-19 | 2026-05-06 |
| Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children VLA15, Normal Saline - Lyme Disease | Phase 3 | Completed | Pfizer | 3547 | 2022-12-12 | 2026-05-07 |
| An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15) VLA15, Saline - Lyme Disease | Phase 3 | Completed | Pfizer | 12546 | 2022-08-04 | 2026-06-04 |
| A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome RLP, Placebo - Post-Lyme Disease Syndrome (PLDS) | Phase 2 / Phase 3 | Completed | Optimal Health Research | 100 | 2019-11-29 | 2021-04-12 |
| Symptomatic Management of Lyme Arthritis Naproxen, Acetaminophen - Lyme Arthritis, Lyme Disease | Phase 3 | Terminated | Desiree Neville, MD | 3 | 2019-10-01 | 2025-11-17 |
| Six Versus Two Weeks Treatment With Doxycycline in Lyme Neuroborreliosis Doxycycline, Placebo - Neuroborreliosis, Borrelia Burgdorferi | Phase 3 | Completed | Sorlandet Hospital HF | 121 | 2015-10-01 | 2024-01-23 |
| Passive Prophylaxis of Lyme Disease Using Permethrin Treated Clothes Permethrin, Placebo - Lyme Disease | Phase 3 | Terminated | University of Minnesota | 61 | 2008-06-01 | 2020-06-04 |
| Effect of Intravenous Ceftriaxone and Oral Doxycycline for Lyme Neuroborreliosis Ceftriaxone, Doxycycline - Lyme Neuroborreliosis | Phase 3 | Completed | Sorlandet Hospital HF | 120 | 2004-03-01 | 2023-05-06 |
| Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever doxycycline treatment - Relapsing Fever, Tick-borne, Jarisch Herxheimer Reaction | Phase 2 / Phase 3 | Completed | Medical Corps, Israel Defense Force | 140 | 2002-04-01 | 2024-12-19 |
| Lyme Disease Prevention Program Education about disease prevention - Lyme Disease, Tick-Borne Diseases | Phase 3 | Completed | Brigham and Women's Hospital | 20000 | 1997-04-01 | 2013-12-24 |
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seronegative Chronic Lyme Disease ceftriaxone, doxycycline - Lyme Disease | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 66 | 2010-08-27 | |
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease ceftriaxone, doxycycline - Lyme Disease | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 194 | 2010-08-27 | |
| Study and Treatment of Post Lyme Disease (STOP-LD) Antibiotics - Lyme Disease | Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 55 | 2010-08-27 |
Lyme Disease (10) · Lyme Neuroborreliosis (3) · Arthritis (1) · Post-Lyme Disease Syndrome (1) · Relapsing Fever (1) · Tick-Borne Diseases (1) · Vector Borne Diseases (1)
Bacterial Infections (14) · Bacterial Infections and Mycoses (14) · Gram-Negative Bacterial Infections (14) · Infections (14) · Spirochaetales Infections (14) · Tick-Borne Diseases (13) · Vector Borne Diseases (13) · Central Nervous System Bacterial Infections (3) · Central Nervous System Diseases (3) · Central Nervous System Infections (3) · Lyme Disease (3) · Nervous System Diseases (3) · Chronic Disease (1) · Disease Attributes (1)
Doxycycline (4) · Ceftriaxone (3) · Acetaminophen (1) · Anti-Bacterial Agents (1) · Naproxen (1) · Permethrin (1) · Saline Solution (1) · Sodium Chloride (1)
Pfizer (4) · National Institute of Allergy and Infectious Diseases (NIAID) (3) · Sorlandet Hospital HF (2) · Brigham and Women's Hospital (1) · Desiree Neville, MD (1) · Medical Corps, Israel Defense Force (1) · Optimal Health Research (1) · University of Minnesota (1)
United States (11) · Canada (2) · Finland (1) · Germany (1) · Israel (1) · Netherlands (1) · Norway (1) · Poland (1) · Sweden (1)
Anne Marit Solheim, M.D (1) · David R. Boulware, MD, MPH (1) · Desiree NW Neville, MD (1) · Matthew H. Liang, MD, MPH (1) · Tal Hasin, MD (1)
PMID 16837678, PMID 18567539, PMID 38262807
2015 (1), 2023 (1), 2025 (1), P60AR036308 (1), R01AI031561 (1)